Patent · US Active

Pyrrolo[2,3-d]pyrimidine derivatives

US10966980B2 · kind B2 · utility

0Cited by
22References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 10, 2015
Grant dateApr 6, 2021
Priority date—
Expiry dateAug 10, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D519/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Described herein are pyrrolo{2,3-d}pyrimidine derivatives, their use as Janus Kinase (JAK) inhibitors, pharmaceutical compositions containing them, and therapeutic uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.